Insiders · PMCB

PMCB insider transactions

PharmaCyte Biotech Inc. (PMCB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PMCB

• 66d
  SEC Form 4 filed by Walker Wayne Remell

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 66d
  SEC Form 4 filed by Weinstein Robert

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 66d
  SEC Form 4 filed by Schechter Jonathan

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 66d
  SEC Form 4 filed by Abecassis Michael M

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 151d
  CEO and President Silverman Joshua bought $80,476 worth of shares (100,000 units at $0.80), increasing direct ownership by 32% to 416,250 units (SEC Form 4)

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 151d
  Director Schechter Jonathan bought $48,232 worth of shares (60,000 units at $0.80), increasing direct ownership by 45% to 192,500 units (SEC Form 4)

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 177d
  Director Weinstein Robert was granted 75,000 shares and covered exercise/tax liability with 33,750 shares (SEC Form 4)

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 177d
  Director Walker Wayne Remell covered exercise/tax liability with 16,875 shares and was granted 37,500 shares (SEC Form 4)

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 177d
  CEO and President Silverman Joshua was granted 575,000 shares and covered exercise/tax liability with 258,750 shares (SEC Form 4)

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 177d
  Director Schechter Jonathan was granted 150,000 shares and covered exercise/tax liability with 67,500 shares, increasing direct ownership by 165% to 132,500 units (SEC Form 4)

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 177d
  Director Abecassis Michael M was granted 37,500 shares and covered exercise/tax liability with 16,875 shares, increasing direct ownership by 1,237% to 22,292 units (SEC Form 4)

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 690d
  SEC Form 4 filed by Director Weinstein Robert

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 690d
  SEC Form 4 filed by Director Walker Wayne Remell

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 690d
  SEC Form 4 filed by Director Schechter Jonathan

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 690d
  SEC Form 4 filed by Director Abecassis Michael M

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 928d
  SEC Form 4 filed by Weinstein Robert

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 928d
  SEC Form 4 filed by Walker Wayne Remell

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 928d
  SEC Form 4 filed by Trujillo Carlos

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 928d
  SEC Form 4 filed by Silverman Joshua

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 928d
  SEC Form 4 filed by Schechter Jonathan

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 928d
  SEC Form 4 filed by Abecassis Michael M

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1255d
  SEC Form 4 filed by Allen Daniel

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1255d
  SEC Form 4 filed by Farb Daniel Stuart

  4 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1255d
  SEC Form 3 filed by new insider Walker Wayne Remell

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1299d
  SEC Form 3 filed by new insider Weinstein Robert

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1383d
  SEC Form 3: New insider Allen Daniel claimed ownership of 260,000 shares

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1384d
  SEC Form 3: New insider Schechter Jonathan claimed ownership of 50,000 shares

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1384d
  SEC Form 3 filed by new insider Stover Jack E

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1384d
  SEC Form 3: New insider Silverman Joshua claimed ownership of 50,000 shares

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1385d
  SEC Form 3: New insider Farb Daniel Stuart claimed ownership of 714,570 shares

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1518d
  SEC Form 3: New insider Loehr Matthias claimed ownership of 3,004 shares

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1738d
  SEC Form 3: New insider Trujillo Carlos claimed ownership of 8,800 units of Common Stock

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1741d
  SEC Form 3: New insider Waggoner Kenneth L. claimed ownership of 20,600 units of Common Stock

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1741d
  SEC Form 3: New insider Yuen Thomas C K claimed ownership of 1,667 units of Common Stock

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1741d
  SEC Form 3: New insider Crabtree Gerald W claimed ownership of 11,200 units of Common Stock

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1752d
  SEC Form 3: Abecassis Michael M claimed ownership of 2,467 units of Common Stock

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1752d
  SEC Form 3: Tong Raymond CF claimed ownership of 1,333 units of Common Stock

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)
• 1752d
  SEC Form 3: Liquard Thomas claimed ownership of 1,667 units of Common Stock

  3 - PharmaCyte Biotech, Inc. (0001157075) (Issuer)